Steven Quay, a biopharmaceutical executive and advocate of the COVID-19 lab leak theory, is no longer the leading candidate to direct the National Institute for Allergy and Infectious Diseases, according to reporting published by STAT.
Plain-Language Summary of the Leadership Shift
- The Candidate: Steven Quay, a biopharmaceutical executive with no background in infectious diseases, was under consideration to lead the National Institute for Allergy and Infectious Diseases.
- The Role: The position was once held by Anthony Fauci.
- The Decision: Quay is now expected to take on more of a consulting role for the center rather than securing the directorship.
The Shift in Consideration for the National Institute for Allergy and Infectious Diseases
Steven Quay, a biopharmaceutical executive known for his early advocacy for the theory that the Covid-19 virus was engineered in and leaked from a lab in China, was being considered for an appointment as director of the National Institute for Allergy and Infectious Diseases at the National Institutes of Health. That agency operates under the National Institutes of Health.
According to a source with knowledge of the decision who spoke with STAT, Quay is no longer the leading choice to lead the institute. Instead, the expectation is that he will take on more of a consulting role for the center. The White House and the Department of Health and Human Services did not respond to requests for comment. Quay did not respond.
Background on the Proposed Leadership and Scientific Debates
The potential selection of Quay introduced a profile to a role once held by Anthony Fauci. Quay’s professional background is in biopharmaceuticals, with no background in infectious diseases. His visibility grew during the pandemic due to his promotion of the lab leak theory.
The origin of the virus remains a subject of inquiry.
Future Administrative Decisions and Next Steps
As the administration weighs its leadership options for the National Institute for Allergy and Infectious Diseases, the timeline for a formal nomination or advisory appointment remains unconfirmed. Further announcements from the Department of Health and Human Services are anticipated as administrative staffing decisions are finalized.
References
- STAT. “Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role.”
